A61K 40/4544
Pseudomonadales
Official title: {Pseudomonadales, e.g. Pseudomonas}
A61K40/4544 (Pseudomonadales) appears on 3 US grants and 8 published applications in this corpus.
Search patents in A61K- Granted patents
- 3
- Published applications
- 8
- Assignees
- 7
- Inventors
- 21
- Latest grant
- 9 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Generation of functional neutrophils and macrophages from induced pluripotent stem cells in chemically defined conditions using transient expression of ETV29 Sep 2025US 12,410,401 B2Wisconsin Alumni Research Foundation (WARF)
- Methods for generating universal and custom MHC/HLA-compatible hematopoietic progenitor cells31 Jan 2023US 11,564,942 B2President and Fellows of Harvard College
- De novo induction of cells exhibiting characteristics of macrophages utilizing feline sarcoma virus30 Sep 1997US 5,672,493 A
- Generation of functional neutrophils and macrophages from induced pluripotent stem cells in chemically defined conditions using transient expression of etv212 Feb 2026US 2026/0043002 A1
- Stem-cell derived myeloid cells, generation and use thereof27 May 2021US 2021/0155902 A1Medizinische Hochschule Hannover
- Autologous and allogenic macrophages and monocytes for use in therapeutic methods6 May 2021US 2021/0128611 A1Cellular Approaches, Inc.
- Generation of functional neutrophils and macrophages from induced pluripotent stem cells in chemically defined conditions using transient expression of etv210 Dec 2020US 2020/0385676 A1Wisconsin Alumni Research Foundation (WARF)
- Enriched Cellular Compositions and Therapeutic Use21 May 2020US 2020/0155607 A1Abraham J and Phyllis Katz Cord Blood Foundation
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.